- Home
- CAC vs ARCT Comparison
CAC vs ARCT Comparison
Compare CAC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ARCT
- Stock Information
- Founded
- CAC 1875
- ARCT 2013
- Country
- CAC United States
- ARCT United States
- Employees
- CAC N/A
- ARCT N/A
- Industry
- CAC Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ARCT Health Care
- Exchange
- CAC Nasdaq
- ARCT Nasdaq
- Market Cap
- CAC 688.3M
- ARCT 320.8M
- IPO Year
- CAC 1997
- ARCT N/A
- Fundamental
- Price
- CAC $41.52
- ARCT $19.62
- Analyst Decision
- CAC Buy
- ARCT Strong Buy
- Analyst Count
- CAC 3
- ARCT 10
- Target Price
- CAC $48.00
- ARCT $50.88
- AVG Volume (30 Days)
- CAC 55.2K
- ARCT 503.6K
- Earning Date
- CAC 10-28-2025
- ARCT 11-06-2025
- Dividend Yield
- CAC 4.22%
- ARCT N/A
- EPS Growth
- CAC 4.80
- ARCT N/A
- EPS
- CAC 3.11
- ARCT N/A
- Revenue
- CAC $197,501,000.00
- ARCT $122,122,000.00
- Revenue This Year
- CAC $42.11
- ARCT N/A
- Revenue Next Year
- CAC $5.51
- ARCT $28.92
- P/E Ratio
- CAC $12.79
- ARCT N/A
- Revenue Growth
- CAC 21.74
- ARCT N/A
- 52 Week Low
- CAC $34.53
- ARCT $8.04
- 52 Week High
- CAC $50.07
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- CAC 61.00
- ARCT 67.57
- Support Level
- CAC $39.50
- ARCT $17.70
- Resistance Level
- CAC $40.75
- ARCT $19.50
- Average True Range (ATR)
- CAC 0.89
- ARCT 1.09
- MACD
- CAC 0.01
- ARCT 0.01
- Stochastic Oscillator
- CAC 99.51
- ARCT 98.01
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.